
Patient satisfaction with GP services in England has collapsed, research finds
The proportion of patients seeing a GP in person has plummeted from more than four-fifths (80.7%) in 2019 to just under two-thirds (66.2%) last year.
Telephone appointments have almost doubled over the same period from 13.4% to 25.4%. Those undertaken by video or online, including some in which patients fill in an online form but have no direct interaction with a GP, have risen almost eightfold from 0.6% to 4.6%.
The Institute for Government (IFG) thinktank also found patients valued face-to-face appointments so highly that they regarded them as more important than their GP surgery offering more appointments overall by maximising the number provided remotely.
They are more satisfied with practices that offer more in-person sessions, and less satisfied with those relying more on telephone and remote consultations, even though those free GPs up to see more patients.
The dramatic shift in how family doctors interact with patients has coincided with a huge fall in public satisfaction with GP services.
'Patient satisfaction is higher in practices that deliver more of their appointments face to face,' according to an IFG report tracking the performance of England's 6,200 GP surgeries since 2019. Surgeries that offer the most remote appointments have experienced the biggest falls in satisfaction, the IFG analysis shows.
Practices where in-person appointments remain common are also better at managing diseases such as asthma and diabetes, managing smoking and obesity, and providing check-ups to spot illness early, such as health screening and blood pressure checks, the thinktank found.
Remote ways of providing care to patients that became commonplace as Covid-19 hit in 2020, which were widely thought at the time to be temporary, have become established ways of doing so at many GP surgeries, even though patients prefer traditional face-to-face appointments.
Surveys have found that patients' satisfaction with GP services has fallen dramatically over recent years. Only 31% of people in Britain are satisfied with GP services, and just 23% with GP waiting times, the recent British Social Attitudes survey found.
Silver Voices, a not-for-profit campaign group for over-60s, said GP care should not be reduced to 'intermittent telephone conversations' and that the lack of face-to-face appointments undermined Wes Streeting's repeated pledge to 'bring back the family doctor'.
Dennis Reed, the group's director, said: 'Older patients are particularly affected by more remote consultations as we are more likely to be living with multiple conditions which require personal examination, rather than the need to just treat immediate symptoms.
'Many older patients are also uncomfortable about discussing intimate issues remotely, and the risks of misdiagnosis therefore increases.'
Ministers should legislate to give patients a legal right to an in-person appointment, he said.
GP leaders responded to the IFG's conclusions by stressing that surgeries were so overstretched that remote appointments were needed to help them keep up with the growing demand for care.
Prof Kamila Hawthorne, the chair of the Royal College of GPs, said: 'We recognise that many patients want to see their GP face to face and the majority of GP appointments are carried out face to face – 64% in February. However, we also know that many patients appreciate the convenience of remote appointments, which can be delivered safely and securely with virtual technologies or over the phone.
'The unfortunate reality is that general practice today is totally overstretched. Patient need for GP care and services continues to outstrip resources following years of neglect and underfunding by successive governments.
'GPs and our teams are now delivering more appointments than ever before – 367m last year, more than a million per day – but with just a handful of more qualified GPs than in 2019.'
Stuart Hoddinott, a senior researcher at the IFG and co-author of the Nuffield Foundation-funded report, said the relentless demand for care and shortage of GPs meant patients should not expect in-person appointments to return to pre-Covid levels.
He said: 'The pandemic-era shift to providing many more appointments remotely can explain some – though not all – of the collapse in patient satisfaction.
'Although patients, especially those over 65, seem to prefer face-to-face appointments overall, the need to deliver ever more appointments to cope with demand in the system makes a return to pre-pandemic levels of face-to-face appointments unlikely.'
The report, which was based on analysis of a range of official data about GP services, also found that:
There are too few full-time GPs for the health secretary to fulfil his promise to 'bring back the family doctor', and that is unlikely to change in the years ahead.
The government's policy of pushing GPs to offer more appointments may not be 'wise' because GPs will respond by providing more remotely – which patients dislike.
GP appointment times will need to be extended from 10 to 15 minutes if Streeting is to deliver his pledge to shift the NHS from a treatment to much more of an illness prevention service.
If GPs shift to being more preventive in their work, that might reduce the number of appointments they can offer, because patients will need more time to discuss their health.
The Department of Health and Social Care insisted that patients who wanted an in-person consultation should get one.
A spokesperson said: 'GP services are buckling after years of neglect but through our plan for change, we are working with GPs to fix the front door of the NHS and bring back the family doctor. By cutting red tape and investing more in our NHS, we have recruited more than 1,500 GPs to deliver more appointments.
'This government is also clear that patients should have access to health and care when they need it and people who prefer a face-to-face appointment should have one.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
4 hours ago
- The Independent
Baroness Amos to lead NHS maternity and neonatal investigation
The Royal College of Midwives (RCM) has welcomed the selection of Baroness Valerie Amos to lead the investigation into NHS maternity and neonatal care, adding it is 'vital' the review gets under way quickly. Baroness Amos was selected by Health Secretary Wes Streeting after bereaved families expressed a preference for someone with distance from the NHS who is able to bring a fresh pair of eyes to the role, the Department of Health and Social Care (DHSC) said. Mr Streeting has been meeting bereaved and harmed families who have been let down by maternity and neonatal services across the country, including in some of the worst affected trusts, DHSC added. In June, he announced that a national investigation into 'systemic' failures in NHS maternity care had been launched by the Government after families were 'gaslit' in their search for the truth. Baroness Amos is master of University College, Oxford, and was a UK Government minister and a senior official at the United Nations. Mr Streeting said: 'I have been appalled by the many harrowing stories I've heard from mothers and fathers let down by the NHS. ' Families asked for fresh eyes, independence and compassion – and that's why I've appointed Baroness Amos. Valerie has an outstanding record of leadership and driving change, nationally and internationally. She will work closely with families to uncover the truth, confront problems and drive the improvements needed so every woman and baby receives safe, high-quality care. 'Through our Plan for Change, we will rebuild the NHS to ensure no family suffers like this again.' Baroness Amos said: 'I will carry the weight of the loss suffered by families with me throughout this investigation. I hope that we will be able to provide the answers that families are seeking and support the NHS in identifying areas of care requiring urgent reform.' The investigation will look at up to 10 services in the country. It will also review the maternity and neonatal system, bringing together the findings of past reviews into one national set of actions, the DHSC said. It will begin work this summer and produce an initial set of national recommendations by December. The 10 maternity and neonatal units will be decided by Baroness Amos and her team, alongside the terms of reference of the investigation, which are being developed with families who have experiences of maternity and neonatal care, including in Leeds, Sussex and Nottingham, the DHSC added. The investigation is separate from the National Maternity and Neonatal Taskforce, which will be made up of a panel of experts and families, and chaired by Mr Streeting. Gill Walton, chief executive of the RCM, said: 'We are pleased to hear of the appointment of Baroness Amos as chair of the rapid review. She has a reputation for taking a thoughtful and strategic approach and we welcome her fresh insight into maternity and neonatal safety. 'It is absolutely vital, though, that this review gets under way quickly. When he announced it in June, we welcomed Wes Streeting's commitment to publishing the review by Christmas, a promise he repeated at the Progress in Partnership summit on maternity and neonatal safety last month. 'However, we are already halfway through August, with no terms of reference, no sense of the trusts who are likely to be part of the review or no clarity on how the review will be conducted. 'Every woman and family should leave maternity and neonatal services whole, happy and healthy, and every member of maternity staff should start and end their shift knowing they have provided safe, good-quality care. 'At the moment, that simply isn't the case. Previous reviews and countless Care Quality Commission reports have flagged the same the systemic failings that are at the heart of the issues facing maternity and neonatal care issues time and time again: unsafe staffing, poor workplace cultures, and not listening to women. 'In spite of that, there has been no forward movement. Wes Streeting promised to change that. Thousands of midwives and maternity support workers, and the whole of the maternity community, are desperate for him to keep that promise and deliver the change we all want to see.' The RCM has also urged the review to look at examples of good maternity care, as well as where services are not meeting standards of care.


Times
7 hours ago
- Times
Junior doctors strikes: NHS staff absence due to walkouts falls
NHS staff absences due to industrial action fell by 7.5 per cent compared with the last round of junior doctors' strikes, with 1,243 fewer staff absent during the most recent walkout. The analysis from the health service also found that more care was delivered during the five-day strike than in previous industrial action. Junior doctors, now known as resident doctors in the NHS, walked out for five days on July 25 in a dispute with the government over pay. Wes Streeting, the health secretary, and the British Medical Association (BMA) say they are continuing talks over the summer to prevent further strike action from the doctors. The NHS estimated that 11,071 more appointments and procedures went ahead as planned compared with industrial action from junior doctors in 2024. In previous industrial action, hospitals cancelled or rescheduled elective procedures to prepare for the walkouts. However, during this round of strikes, hospitals endeavoured to keep planned appointments going ahead as scheduled throughout the walk-outs. Streeting said the figures show the NHS 'was more resilient against last month's strike action than ever before'. 'We are getting on with the job of delivering progress in the face of strike action, and we will continue to put patients first,' he said. 'I had a constructive conversation with the BMA last week and I am glad they've agreed to continue engagement through the summer with the mutual aim of preventing further disruption to the NHS and patients.' Professor Meghana Pandit, NHS national medical director, said: 'It is very welcome news that the resident doctors committee has returned to talks, and we hope this leads to a resolution that avoids further disruption for patients.' Daniel Elkeles, chief executive of NHS Providers, which represents hospital trusts, said: 'Despite a five-day strike in July by some doctors, the NHS provided an estimated 11,000 more appointments and procedures compared to during their five-day walkout in July last year.' • NHS patients told to brace for strikes until Christmas and beyond 'We hope that talks between the union and the government bear fruit and that any more disruptive strikes can be avoided. NHS trust leaders want to focus on improving services for patients and doing everything they can to improve things for valued resident doctors.' The doctors' union has, however, said that the action 'was totally avoidable'. It has previously said that the difference in absences could not be accurately compared between the strike years due to changes in the numbers taking annual leave. A spokesman added: 'Had the government just come forward with a credible offer toward pay restoration for resident doctors, those doctors would have been at work. Instead, government inaction meant we saw yet more cancellations, delays and chaos in a health system that is already seeing far too much of all three. 'We hope government uses the opportunity of our ongoing talks to avoid any need for future action. Today's figures show there are far too many patients on waiting lists relying on a swift and just resolution to this dispute.' Separate NHS figures show that the health service delivered a record number of appointments in June, with 103,563 more treatments carried out than this time last year. The latest performance data from NHS England shows an estimated 7.37 million treatments were waiting to be carried out at the end of June, relating to 6.23 million patients — up from 7.36 million treatments and just under 6.23 million patients at the end of May. The slight increase, which NHS officials have put down to more people coming forward for appointments, comes after the list fell for two consecutive months. The numbers waiting for more than 18 months to start treatment were also down to 1,103, from 1,237 in May. Some 10,517 patients had been waiting more than 65 weeks, down from 11,522 the previous month. This figure stood at 58,024 in June 2024. The number of patients waiting more than 52 weeks to start routine treatment also fell to 191,813 from 196,920 at the end of May. Tim Gardner, assistant director of policy at the Health Foundation, said: 'While summer is often a time for the NHS to catch its breath, today's data shows hospitals and ambulance services remain under relentless pressure.'


Glasgow Times
7 hours ago
- Glasgow Times
Mounjaro prices double as weight loss jab popularity soars
US-based Eli Lilly says a 5mg dose will nearly double from £92 to £180 from September 1, while a 15mg pen will rise from £122 to £330. A Lilly spokesperson said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from 1 September to address pricing inconsistencies compared to other developed countries, including in Europe. We have reached an agreement with the NHS to ensure continued supply and patient access." READ NEXT: Mounjaro could be available on prescription by Glasgow health board READ NEXT: Cumbernauld woman's surgery goal after Mounjaro weight loss The statement continues: 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability." More than 1.5 million people in the UK are believed to be using weight-loss medication each month, with most buying the jabs from private pharmacies. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 This comes as the Government has joined forces with Eli Lilly in a bid to tackle obesity. The move could see patients accessing care at pharmacies or by using online platforms. The £85 million programme from Eli Lilly and the Department for Science, Innovation and Technology (DSIT) has been designed to look at how obese patients can access weight management care more easily. This includes through community services, in pharmacies and online. Using these tools, eligible patients could be treated 'in a matter of months', according to Health Secretary Wes Streeting. Under the agreement, the Government will contribute up to £50 million in UK-wide investment. Meanwhile, Eli Lilly will back the programme with £35 million, and NHS organisations will be able to apply for a share of the funding. Recommended reading: Mounjaro warning as pens ruined by heatwave temperatures This comes as users are risking having to throw away perfectly good Mounjaro pens as they have overheated in the recent heatwave. Improper storage of Ozempic, Wegovy and Mounjaro during a heatwave could destroy the active ingredient in these jabs, potentially wiping out their effects entirely, even if the medication looks completely normal. 'We recommend treating your weight-loss pen the same way you'd treat insulin or any critical medication,' says Danielle Brightman, Clinical Director at Numan. 'When in doubt, don't risk it. Speak to a healthcare professional and arrange a replacement.' 8 tips to protect Mounjaro and other weight-loss injections during hot weather Use a medical-grade cool bag. Transport your pen in a proper, insulated container designed for sensitive medications. Don't use improvised ice packs that might freeze the pen by accident. Never leave your pen in hot places. Even 10 minutes in a parked car or on a sunny kitchen counter could expose it to damaging heat if out of its delivery packaging or unrefrigerated. Always check the environment before setting it down. Store below 30°C once in use. Once opened and if not refrigerated, keep your pen in a shaded, ventilated area, away from heat sources, windows, and radiators. If you live in a flat or home without air conditioning, keep the pen in a bedroom or hallway that doesn't heat up from direct sun. Avoid storing near exterior walls if the property retains heat. Follow the usage timeline carefully. The storage instructions between medications. Wegovy after first use can last 6 weeks below 30 degrees then needs to be disposed of, whereas Mounjaro has a shorter time of 30 days below 30 degrees before needing to be disposed of. Stick to that timeframe, and if you're unsure whether it's still safe, consult your provider. Use a fridge thermometer at home. Fridge temperatures can fluctuate, especially in older models or over-packed shelves. A simple digital fridge thermometer can help ensure your pen is always stored between 2–8°C before first use. Planning to travel? Use airline-friendly cooling cases. If you're flying or taking long journeys, consider TSA-approved insulated medication pouches with cooling gel packs. Always store the pen in carry-on luggage, not checked baggage, as cargo holds can get hot or cold. Set storage reminders on your phone. If you're prone to forgetting where you left your pen, set daily reminders to check if it's stored properly, especially during heatwaves or while travelling. Don't store near appliances or steam sources. Keep pens away from kettles, toasters, ovens, dishwashers, and anywhere that might experience sudden heat or humidity, especially in small kitchens or shared spaces. Injections like Ozempic, Wegovy, and Mounjaro are now widely used across the UK for appetite control and sustainable weight management. But despite their growing popularity and increasing availability now through the NHS, most patients don't realise the strict temperature guidelines that must be followed to keep these drugs effective. 'We speak to patients every day who are using GLP-1s for the first time,' says Danielle. 'With temperatures set to soar again this summer, it's crucial we raise awareness about safe medication storage. Heat damage isn't always obvious, but it can have a huge impact on effectiveness and safety."